Medina D - Search Results

1

Prevention of tumorigenesis in p53-null mammary epithelium by rexinoid bexarotene, tyrosine kinase inhibitor gefitinib, and celecoxib.

Medina D, Kittrell F, Hill J, Zhang Y, Hilsenbeck SG, Bissonette R, Brown PH. Medina D, et al. Cancer Prev Res (Phila). 2009 Feb;2(2):168-74. doi: 10.1158/1940-6207.CAPR-08-0107. Epub 2009 Jan 27. Cancer Prev Res (Phila). 2009. PMID: 19174577 Free PMC article.

2

Tamoxifen inhibition of estrogen receptor-alpha-negative mouse mammary tumorigenesis.

Medina D, Kittrell FS, Hill J, Shepard A, Thordarson G, Brown P. Medina D, et al. Cancer Res. 2005 Apr 15;65(8):3493-6. doi: 10.1158/0008.5472.CAN-04-3869. Cancer Res. 2005. PMID: 15833886

3

Ataxia telangiectasia-mutated and p53 are potential mediators of chloroquine-induced resistance to mammary carcinogenesis.

Loehberg CR, Thompson T, Kastan MB, Maclean KH, Edwards DG, Kittrell FS, Medina D, Conneely OM, O'Malley BW. Loehberg CR, et al. Among authors: medina d. Cancer Res. 2007 Dec 15;67(24):12026-33. doi: 10.1158/0008-5472.CAN-07-3058. Cancer Res. 2007. PMID: 18089834

4

Identification of tumor-initiating cells in a p53-null mouse model of breast cancer.

Zhang M, Behbod F, Atkinson RL, Landis MD, Kittrell F, Edwards D, Medina D, Tsimelzon A, Hilsenbeck S, Green JE, Michalowska AM, Rosen JM. Zhang M, et al. Among authors: medina d. Cancer Res. 2008 Jun 15;68(12):4674-82. doi: 10.1158/0008-5472.CAN-07-6353. Cancer Res. 2008. PMID: 18559513 Free PMC article.

5

Identification of modulated genes by three classes of chemopreventive agents at preneoplastic stages in a p53-null mouse mammary tumor model.

Abba MC, Hu Y, Levy CC, Gaddis S, Kittrell FS, Hill J, Bissonnette RP, Brown PH, Medina D, Aldaz CM. Abba MC, et al. Among authors: medina d. Cancer Prev Res (Phila). 2009 Feb;2(2):175-84. doi: 10.1158/1940-6207.CAPR-08-0104. Epub 2009 Jan 27. Cancer Prev Res (Phila). 2009. PMID: 19174580 Free PMC article.

6

The combination of tamoxifen and the rexinoid LG100268 prevents ER-positive and ER-negative mammary tumors in p53-null mammary gland mice.

Mazumdar A, Medina D, Kittrell FS, Zhang Y, Hill JL, Edwards DE, Bissonnette RP, Brown PH. Mazumdar A, et al. Among authors: medina d. Cancer Prev Res (Phila). 2012 Oct;5(10):1195-202. doi: 10.1158/1940-6207.CAPR-11-0524. Epub 2012 Aug 27. Cancer Prev Res (Phila). 2012. PMID: 22926341 Free PMC article.

7

Biological and genetic properties of the p53 null preneoplastic mammary epithelium.

Medina D, Kittrell FS, Shepard A, Stephens LC, Jiang C, Lu J, Allred DC, McCarthy M, Ullrich RL. Medina D, et al. FASEB J. 2002 Jun;16(8):881-3. doi: 10.1096/fj.01-0885fje. Epub 2002 Apr 10. FASEB J. 2002. PMID: 11967232

8

Hormone dependence in premalignant mammary progression.

Medina D, Kittrell FS, Shepard A, Contreras A, Rosen JM, Lydon J. Medina D, et al. Cancer Res. 2003 Mar 1;63(5):1067-72. Cancer Res. 2003. PMID: 12615724

9

p53 function is required for hormone-mediated protection of mouse mammary tumorigenesis.

Medina D, Kittrell FS. Medina D, et al. Cancer Res. 2003 Oct 1;63(19):6140-3. Cancer Res. 2003. PMID: 14559792

10

Hormone-induced chromosomal instability in p53-null mammary epithelium.

Pati D, Haddad BR, Haegele A, Thompson H, Kittrell FS, Shepard A, Montagna C, Zhang N, Ge G, Otta SK, McCarthy M, Ullrich RL, Medina D. Pati D, et al. Among authors: medina d. Cancer Res. 2004 Aug 15;64(16):5608-16. doi: 10.1158/0008-5472.CAN-03-0629. Cancer Res. 2004. PMID: 15313898

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

838 results

Search Page

Filters